nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Fluorouracil—head and neck cancer	0.197	0.352	CbGbCtD
Candesartan—CYP2C9—Fluorouracil—head and neck cancer	0.137	0.245	CbGbCtD
Candesartan—ABCB1—Vinblastine—head and neck cancer	0.124	0.221	CbGbCtD
Candesartan—ABCB1—Docetaxel—head and neck cancer	0.102	0.182	CbGbCtD
Candesartan—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00828	0.0268	CcSEcCtD
Candesartan—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00782	0.0253	CcSEcCtD
Candesartan—Blood urea increased—Hydroxyurea—head and neck cancer	0.00725	0.0234	CcSEcCtD
Candesartan—UGT1A3—Estrogen metabolism—GSTM1—head and neck cancer	0.00565	0.0432	CbGpPWpGaD
Candesartan—UGT1A3—Estrogen metabolism—CYP1A1—head and neck cancer	0.00536	0.041	CbGpPWpGaD
Candesartan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00522	0.0169	CcSEcCtD
Candesartan—Angina pectoris—Vinblastine—head and neck cancer	0.00515	0.0166	CcSEcCtD
Candesartan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00465	0.015	CcSEcCtD
Candesartan—Myocardial infarction—Vinblastine—head and neck cancer	0.00462	0.0149	CcSEcCtD
Candesartan—Neutropenia—Hydroxyurea—head and neck cancer	0.00451	0.0146	CcSEcCtD
Candesartan—Agranulocytosis—Vinblastine—head and neck cancer	0.0044	0.0142	CcSEcCtD
Candesartan—Haemoglobin—Vinblastine—head and neck cancer	0.00425	0.0137	CcSEcCtD
Candesartan—Haemorrhage—Vinblastine—head and neck cancer	0.00423	0.0137	CcSEcCtD
Candesartan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00422	0.0136	CcSEcCtD
Candesartan—Pharyngitis—Vinblastine—head and neck cancer	0.0042	0.0136	CcSEcCtD
Candesartan—Cardiac failure—Fluorouracil—head and neck cancer	0.00411	0.0133	CcSEcCtD
Candesartan—Haemoglobin—Hydroxyurea—head and neck cancer	0.00388	0.0125	CcSEcCtD
Candesartan—Haemorrhage—Hydroxyurea—head and neck cancer	0.00386	0.0125	CcSEcCtD
Candesartan—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00373	0.0285	CbGpPWpGaD
Candesartan—Anaemia—Vinblastine—head and neck cancer	0.0034	0.011	CcSEcCtD
Candesartan—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00339	0.0259	CbGpPWpGaD
Candesartan—Angina pectoris—Fluorouracil—head and neck cancer	0.00338	0.0109	CcSEcCtD
Candesartan—Vertigo—Vinblastine—head and neck cancer	0.00331	0.0107	CcSEcCtD
Candesartan—Leukopenia—Vinblastine—head and neck cancer	0.0033	0.0106	CcSEcCtD
Candesartan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00322	0.0104	CcSEcCtD
Candesartan—UGT1A3—Phase II conjugation—NAT2—head and neck cancer	0.00322	0.0246	CbGpPWpGaD
Candesartan—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00319	0.0103	CcSEcCtD
Candesartan—Hypertension—Vinblastine—head and neck cancer	0.00318	0.0103	CcSEcCtD
Candesartan—Anaemia—Hydroxyurea—head and neck cancer	0.0031	0.01	CcSEcCtD
Candesartan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00305	0.00985	CcSEcCtD
Candesartan—Renal impairment—Docetaxel—head and neck cancer	0.00304	0.00983	CcSEcCtD
Candesartan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00304	0.0232	CbGpPWpGaD
Candesartan—Myocardial infarction—Fluorouracil—head and neck cancer	0.00303	0.0098	CcSEcCtD
Candesartan—Leukopenia—Hydroxyurea—head and neck cancer	0.00301	0.00971	CcSEcCtD
Candesartan—Cardiac failure—Docetaxel—head and neck cancer	0.00297	0.00959	CcSEcCtD
Candesartan—Thrombocytopenia—Vinblastine—head and neck cancer	0.00294	0.00951	CcSEcCtD
Candesartan—Epistaxis—Fluorouracil—head and neck cancer	0.00292	0.00943	CcSEcCtD
Candesartan—Hyponatraemia—Docetaxel—head and neck cancer	0.00291	0.0094	CcSEcCtD
Candesartan—Sinusitis—Fluorouracil—head and neck cancer	0.0029	0.00937	CcSEcCtD
Candesartan—Agranulocytosis—Fluorouracil—head and neck cancer	0.00289	0.00933	CcSEcCtD
Candesartan—Haemoglobin—Fluorouracil—head and neck cancer	0.00279	0.00902	CcSEcCtD
Candesartan—Rhinitis—Fluorouracil—head and neck cancer	0.00278	0.00899	CcSEcCtD
Candesartan—Haemorrhage—Fluorouracil—head and neck cancer	0.00278	0.00897	CcSEcCtD
Candesartan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00276	0.0211	CbGpPWpGaD
Candesartan—Pharyngitis—Fluorouracil—head and neck cancer	0.00276	0.0089	CcSEcCtD
Candesartan—Paraesthesia—Vinblastine—head and neck cancer	0.0027	0.00872	CcSEcCtD
Candesartan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00268	0.00867	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00253	0.0193	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00246	0.00794	CcSEcCtD
Candesartan—Dyspnoea—Hydroxyurea—head and neck cancer	0.00244	0.00789	CcSEcCtD
Candesartan—Angina pectoris—Docetaxel—head and neck cancer	0.00244	0.00788	CcSEcCtD
Candesartan—Somnolence—Hydroxyurea—head and neck cancer	0.00244	0.00787	CcSEcCtD
Candesartan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00241	0.00779	CcSEcCtD
Candesartan—Abdominal pain—Vinblastine—head and neck cancer	0.00238	0.00768	CcSEcCtD
Candesartan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00237	0.00764	CcSEcCtD
Candesartan—Fatigue—Hydroxyurea—head and neck cancer	0.00236	0.00763	CcSEcCtD
Candesartan—Neutropenia—Docetaxel—head and neck cancer	0.00234	0.00756	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—KISS1—head and neck cancer	0.00223	0.0171	CbGpPWpGaD
Candesartan—Anaemia—Fluorouracil—head and neck cancer	0.00223	0.00722	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.00221	0.0169	CbGpPWpGaD
Candesartan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.0022	0.00711	CcSEcCtD
Candesartan—Renal failure—Docetaxel—head and neck cancer	0.00219	0.00709	CcSEcCtD
Candesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.00219	0.0168	CbGpPWpGaD
Candesartan—Myocardial infarction—Docetaxel—head and neck cancer	0.00219	0.00707	CcSEcCtD
Candesartan—Body temperature increased—Hydroxyurea—head and neck cancer	0.00217	0.007	CcSEcCtD
Candesartan—Leukopenia—Fluorouracil—head and neck cancer	0.00216	0.00699	CcSEcCtD
Candesartan—Asthenia—Vinblastine—head and neck cancer	0.00216	0.00697	CcSEcCtD
Candesartan—Epistaxis—Docetaxel—head and neck cancer	0.00211	0.0068	CcSEcCtD
Candesartan—Agranulocytosis—Docetaxel—head and neck cancer	0.00208	0.00673	CcSEcCtD
Candesartan—Chest pain—Fluorouracil—head and neck cancer	0.00206	0.00665	CcSEcCtD
Candesartan—Myalgia—Fluorouracil—head and neck cancer	0.00206	0.00665	CcSEcCtD
Candesartan—Diarrhoea—Vinblastine—head and neck cancer	0.00206	0.00664	CcSEcCtD
Candesartan—Haemoglobin—Docetaxel—head and neck cancer	0.00201	0.00651	CcSEcCtD
Candesartan—Rhinitis—Docetaxel—head and neck cancer	0.00201	0.00649	CcSEcCtD
Candesartan—Hepatitis—Docetaxel—head and neck cancer	0.002	0.00647	CcSEcCtD
Candesartan—Haemorrhage—Docetaxel—head and neck cancer	0.002	0.00647	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.002	0.0153	CbGpPWpGaD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00199	0.0152	CbGpPWpGaD
Candesartan—Pharyngitis—Docetaxel—head and neck cancer	0.00199	0.00643	CcSEcCtD
Candesartan—Dizziness—Vinblastine—head and neck cancer	0.00199	0.00642	CcSEcCtD
Candesartan—Urinary tract disorder—Docetaxel—head and neck cancer	0.00198	0.00639	CcSEcCtD
Candesartan—Oedema peripheral—Docetaxel—head and neck cancer	0.00197	0.00638	CcSEcCtD
Candesartan—Asthenia—Hydroxyurea—head and neck cancer	0.00197	0.00635	CcSEcCtD
Candesartan—Urethral disorder—Docetaxel—head and neck cancer	0.00196	0.00635	CcSEcCtD
Candesartan—AGTR1—Arf6 trafficking events—CDH1—head and neck cancer	0.00194	0.0148	CbGpPWpGaD
Candesartan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00193	0.00624	CcSEcCtD
Candesartan—Tachycardia—Fluorouracil—head and neck cancer	0.00193	0.00622	CcSEcCtD
Candesartan—Vomiting—Vinblastine—head and neck cancer	0.00191	0.00617	CcSEcCtD
Candesartan—Headache—Vinblastine—head and neck cancer	0.00188	0.00608	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—NAT2—head and neck cancer	0.00188	0.0144	CbGpPWpGaD
Candesartan—Diarrhoea—Hydroxyurea—head and neck cancer	0.00188	0.00606	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00186	0.0142	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—NAT2—head and neck cancer	0.00186	0.0142	CbGpPWpGaD
Candesartan—Hypotension—Fluorouracil—head and neck cancer	0.00184	0.00596	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—GRP—head and neck cancer	0.00184	0.0141	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFA—head and neck cancer	0.00182	0.0139	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00182	0.0139	CbGpPWpGaD
Candesartan—Dizziness—Hydroxyurea—head and neck cancer	0.00181	0.00586	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.00181	0.0138	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0018	0.00581	CcSEcCtD
Candesartan—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00179	0.0137	CbGpPWpGaD
Candesartan—Nausea—Vinblastine—head and neck cancer	0.00179	0.00577	CcSEcCtD
Candesartan—Paraesthesia—Fluorouracil—head and neck cancer	0.00177	0.00572	CcSEcCtD
Candesartan—Dyspnoea—Fluorouracil—head and neck cancer	0.00176	0.00568	CcSEcCtD
Candesartan—Mental disorder—Docetaxel—head and neck cancer	0.00176	0.00567	CcSEcCtD
Candesartan—Somnolence—Fluorouracil—head and neck cancer	0.00175	0.00567	CcSEcCtD
Candesartan—Malnutrition—Docetaxel—head and neck cancer	0.00174	0.00564	CcSEcCtD
Candesartan—Vomiting—Hydroxyurea—head and neck cancer	0.00174	0.00563	CcSEcCtD
Candesartan—Dyspepsia—Fluorouracil—head and neck cancer	0.00174	0.00561	CcSEcCtD
Candesartan—Rash—Hydroxyurea—head and neck cancer	0.00173	0.00558	CcSEcCtD
Candesartan—Dermatitis—Hydroxyurea—head and neck cancer	0.00173	0.00558	CcSEcCtD
Candesartan—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00172	0.0132	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.00172	0.0131	CbGpPWpGaD
Candesartan—Headache—Hydroxyurea—head and neck cancer	0.00172	0.00555	CcSEcCtD
Candesartan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0017	0.0055	CcSEcCtD
Candesartan—Back pain—Docetaxel—head and neck cancer	0.00169	0.00545	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00165	0.0126	CbGpPWpGaD
Candesartan—Nausea—Hydroxyurea—head and neck cancer	0.00163	0.00526	CcSEcCtD
Candesartan—Anaemia—Docetaxel—head and neck cancer	0.00161	0.00521	CcSEcCtD
Candesartan—UGT1A3—Phase II conjugation—GSTM1—head and neck cancer	0.00159	0.0121	CbGpPWpGaD
Candesartan—Urticaria—Fluorouracil—head and neck cancer	0.00157	0.00506	CcSEcCtD
Candesartan—Leukopenia—Docetaxel—head and neck cancer	0.00156	0.00505	CcSEcCtD
Candesartan—Body temperature increased—Fluorouracil—head and neck cancer	0.00156	0.00504	CcSEcCtD
Candesartan—Palpitations—Docetaxel—head and neck cancer	0.00154	0.00498	CcSEcCtD
Candesartan—Cough—Docetaxel—head and neck cancer	0.00152	0.00492	CcSEcCtD
Candesartan—Hypertension—Docetaxel—head and neck cancer	0.00151	0.00487	CcSEcCtD
Candesartan—Chest pain—Docetaxel—head and neck cancer	0.00149	0.0048	CcSEcCtD
Candesartan—Arthralgia—Docetaxel—head and neck cancer	0.00149	0.0048	CcSEcCtD
Candesartan—Myalgia—Docetaxel—head and neck cancer	0.00149	0.0048	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00148	0.0113	CbGpPWpGaD
Candesartan—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.00146	0.0111	CbGpPWpGaD
Candesartan—AGTR1—Arf6 signaling events—EGFR—head and neck cancer	0.00143	0.011	CbGpPWpGaD
Candesartan—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.00143	0.0109	CbGpPWpGaD
Candesartan—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.0014	0.0107	CbGpPWpGaD
Candesartan—Pruritus—Fluorouracil—head and neck cancer	0.0014	0.00451	CcSEcCtD
Candesartan—Thrombocytopenia—Docetaxel—head and neck cancer	0.00139	0.0045	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00139	0.0107	CbGpPWpGaD
Candesartan—Tachycardia—Docetaxel—head and neck cancer	0.00139	0.00449	CcSEcCtD
Candesartan—Diarrhoea—Fluorouracil—head and neck cancer	0.00135	0.00436	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00135	0.0103	CbGpPWpGaD
Candesartan—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00133	0.0102	CbGpPWpGaD
Candesartan—Hypotension—Docetaxel—head and neck cancer	0.00133	0.0043	CcSEcCtD
Candesartan—Dizziness—Fluorouracil—head and neck cancer	0.0013	0.00421	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0013	0.00419	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—CASP8—head and neck cancer	0.00129	0.00988	CbGpPWpGaD
Candesartan—Paraesthesia—Docetaxel—head and neck cancer	0.00128	0.00413	CcSEcCtD
Candesartan—Dyspnoea—Docetaxel—head and neck cancer	0.00127	0.0041	CcSEcCtD
Candesartan—Somnolence—Docetaxel—head and neck cancer	0.00127	0.00409	CcSEcCtD
Candesartan—Vomiting—Fluorouracil—head and neck cancer	0.00125	0.00405	CcSEcCtD
Candesartan—Dyspepsia—Docetaxel—head and neck cancer	0.00125	0.00405	CcSEcCtD
Candesartan—Rash—Fluorouracil—head and neck cancer	0.00124	0.00402	CcSEcCtD
Candesartan—Dermatitis—Fluorouracil—head and neck cancer	0.00124	0.00401	CcSEcCtD
Candesartan—Headache—Fluorouracil—head and neck cancer	0.00124	0.00399	CcSEcCtD
Candesartan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00123	0.00397	CcSEcCtD
Candesartan—Fatigue—Docetaxel—head and neck cancer	0.00123	0.00397	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00122	0.00932	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00119	0.00912	CbGpPWpGaD
Candesartan—Nausea—Fluorouracil—head and neck cancer	0.00117	0.00379	CcSEcCtD
Candesartan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00116	0.00376	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.00113	0.00866	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—KISS1—head and neck cancer	0.00113	0.00861	CbGpPWpGaD
Candesartan—Body temperature increased—Docetaxel—head and neck cancer	0.00113	0.00364	CcSEcCtD
Candesartan—Abdominal pain—Docetaxel—head and neck cancer	0.00113	0.00364	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.00108	0.00824	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00107	0.00815	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.00106	0.0081	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—GSTM1—head and neck cancer	0.00106	0.0081	CbGpPWpGaD
Candesartan—Asthenia—Docetaxel—head and neck cancer	0.00102	0.0033	CcSEcCtD
Candesartan—Pruritus—Docetaxel—head and neck cancer	0.00101	0.00325	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL2—head and neck cancer	0.000977	0.00747	CbGpPWpGaD
Candesartan—Diarrhoea—Docetaxel—head and neck cancer	0.000974	0.00315	CcSEcCtD
Candesartan—Dizziness—Docetaxel—head and neck cancer	0.000942	0.00304	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.000935	0.00715	CbGpPWpGaD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000934	0.00714	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—GSTM1—head and neck cancer	0.000929	0.0071	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—GRP—head and neck cancer	0.000928	0.00709	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—GSTM1—head and neck cancer	0.000916	0.007	CbGpPWpGaD
Candesartan—Vomiting—Docetaxel—head and neck cancer	0.000905	0.00292	CcSEcCtD
Candesartan—Rash—Docetaxel—head and neck cancer	0.000898	0.0029	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000898	0.00686	CbGpPWpGaD
Candesartan—Dermatitis—Docetaxel—head and neck cancer	0.000897	0.0029	CcSEcCtD
Candesartan—Headache—Docetaxel—head and neck cancer	0.000892	0.00288	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—CYP1A1—head and neck cancer	0.000881	0.00673	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00087	0.00665	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000869	0.00664	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000861	0.00658	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000856	0.00655	CbGpPWpGaD
Candesartan—Nausea—Docetaxel—head and neck cancer	0.000846	0.00273	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—VEGFA—head and neck cancer	0.00083	0.00635	CbGpPWpGaD
Candesartan—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000793	0.00606	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—UROD—head and neck cancer	0.000775	0.00592	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.000764	0.00584	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000744	0.00569	CbGpPWpGaD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000734	0.00561	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000708	0.00541	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000701	0.00536	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000684	0.00523	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000675	0.00516	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—KISS1—head and neck cancer	0.000637	0.00487	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000606	0.00463	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000603	0.00461	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000598	0.00457	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KISS1—head and neck cancer	0.000578	0.00442	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000557	0.00426	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000549	0.0042	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GRP—head and neck cancer	0.000524	0.00401	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000523	0.004	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000512	0.00391	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000504	0.00385	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000501	0.00383	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000496	0.00379	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000491	0.00375	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GRP—head and neck cancer	0.000476	0.00364	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000456	0.00349	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—UROD—head and neck cancer	0.000436	0.00334	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000417	0.00319	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000379	0.0029	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000353	0.0027	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KISS1—head and neck cancer	0.000342	0.00261	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000338	0.00259	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000338	0.00258	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000335	0.00256	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000335	0.00256	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000333	0.00255	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000325	0.00249	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NAT2—head and neck cancer	0.000322	0.00246	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.00032	0.00245	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000316	0.00242	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000291	0.00223	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000287	0.00219	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—DPYD—head and neck cancer	0.000282	0.00216	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—UROD—head and neck cancer	0.000282	0.00215	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000281	0.00215	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GRP—head and neck cancer	0.000281	0.00215	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000275	0.00211	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000275	0.0021	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000274	0.00209	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT6—head and neck cancer	0.000273	0.00209	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000271	0.00207	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000269	0.00206	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—YAP1—head and neck cancer	0.000268	0.00205	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000261	0.00199	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000257	0.00197	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—UROD—head and neck cancer	0.000246	0.00188	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000244	0.00186	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—YAP1—head and neck cancer	0.000242	0.00185	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UROD—head and neck cancer	0.000229	0.00175	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000219	0.00167	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000192	0.00147	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00019	0.00146	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000187	0.00143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAT2—head and neck cancer	0.000181	0.00139	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.00018	0.00137	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000178	0.00136	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TYMS—head and neck cancer	0.000161	0.00123	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000161	0.00123	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—head and neck cancer	0.000159	0.00121	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—DPYD—head and neck cancer	0.000159	0.00121	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000153	0.00117	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPX1—head and neck cancer	0.000152	0.00116	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—YAP1—head and neck cancer	0.000151	0.00115	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1A1—head and neck cancer	0.000151	0.00115	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—head and neck cancer	0.00014	0.00107	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000138	0.00105	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000133	0.00102	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—head and neck cancer	0.000127	0.00097	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000124	0.00095	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000123	0.000941	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00012	0.000919	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000117	0.000895	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000114	0.00087	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000113	0.000866	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000109	0.000833	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000108	0.000827	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000108	0.000827	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—DPYD—head and neck cancer	0.000103	0.000784	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—head and neck cancer	0.000102	0.00078	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAT2—head and neck cancer	0.000102	0.000779	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000101	0.000773	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.0001	0.000765	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.88e-05	0.000755	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—YAP1—head and neck cancer	9.74e-05	0.000744	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—head and neck cancer	9.71e-05	0.000742	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—head and neck cancer	9.71e-05	0.000742	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAT2—head and neck cancer	9.52e-05	0.000728	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.39e-05	0.000718	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	9.28e-05	0.000709	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.09e-05	0.000695	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMS—head and neck cancer	9.05e-05	0.000692	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—head and neck cancer	8.96e-05	0.000685	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—head and neck cancer	8.95e-05	0.000684	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DPYD—head and neck cancer	8.94e-05	0.000683	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—head and neck cancer	8.57e-05	0.000655	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—YAP1—head and neck cancer	8.48e-05	0.000649	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1A1—head and neck cancer	8.48e-05	0.000648	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—head and neck cancer	8.42e-05	0.000644	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DPYD—head and neck cancer	8.35e-05	0.000638	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—YAP1—head and neck cancer	7.93e-05	0.000606	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—head and neck cancer	7.81e-05	0.000597	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—head and neck cancer	7.79e-05	0.000596	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.67e-05	0.000587	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—head and neck cancer	7.58e-05	0.000579	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—head and neck cancer	7.5e-05	0.000573	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.32e-05	0.000559	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—head and neck cancer	7.31e-05	0.000559	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—head and neck cancer	7.05e-05	0.000539	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.97e-05	0.000533	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—head and neck cancer	6.88e-05	0.000526	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.38e-05	0.000488	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—head and neck cancer	6.37e-05	0.000487	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—head and neck cancer	6.31e-05	0.000482	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—head and neck cancer	6.03e-05	0.000461	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.95e-05	0.000455	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMS—head and neck cancer	5.85e-05	0.000447	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—head and neck cancer	5.78e-05	0.000442	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—head and neck cancer	5.73e-05	0.000438	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—head and neck cancer	5.73e-05	0.000438	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—head and neck cancer	5.53e-05	0.000423	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—head and neck cancer	5.51e-05	0.000421	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A1—head and neck cancer	5.48e-05	0.000419	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.19e-05	0.000397	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMS—head and neck cancer	5.09e-05	0.000389	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—head and neck cancer	5.04e-05	0.000386	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—head and neck cancer	5.04e-05	0.000385	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—head and neck cancer	4.98e-05	0.00038	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—head and neck cancer	4.82e-05	0.000369	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—head and neck cancer	4.81e-05	0.000368	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A1—head and neck cancer	4.77e-05	0.000365	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMS—head and neck cancer	4.76e-05	0.000364	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.7e-05	0.00036	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—head and neck cancer	4.6e-05	0.000352	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—head and neck cancer	4.5e-05	0.000344	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.5e-05	0.000344	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—head and neck cancer	4.5e-05	0.000344	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.46e-05	0.000341	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—head and neck cancer	4.4e-05	0.000336	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—head and neck cancer	4.06e-05	0.000311	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.66e-05	0.00028	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.26e-05	0.000249	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—head and neck cancer	3.1e-05	0.000237	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—head and neck cancer	2.84e-05	0.000217	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—head and neck cancer	2.84e-05	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.65e-05	0.000203	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—head and neck cancer	2.54e-05	0.000194	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—head and neck cancer	2.48e-05	0.000189	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—head and neck cancer	2.31e-05	0.000177	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2e-05	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.75e-05	0.000134	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—head and neck cancer	1.64e-05	0.000125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.63e-05	0.000125	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—head and neck cancer	1.43e-05	0.000109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—head and neck cancer	1.33e-05	0.000102	CbGpPWpGaD
